Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 916 AL 930

Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?

Silvestro S, Valeri A, Mazzon E.

Int J Mol Sci. 2022 Feb 11;23(4):2011. doi: 10.3390/ijms23042011.

Anthocyanin as a therapeutic in Alzheimer's disease: A systematic review of preclinical evidences

Suresh S, Begum RF, Singh S A, V C.

Ageing Res Rev. 2022 Apr;76:101595. doi: 10.1016/j.arr.2022.101595. Epub 2022 Feb 23.

"Exceptions that prove the rule"-Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome?

Breitner JCS, Dodge HH, Khachaturian ZS, Khachaturian AS.

Alzheimers Dement. 2022 Mar;18(3):389-392. doi: 10.1002/alz.12633. Epub 2022 Mar 4.

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease

Bairamian D, Sha S, Rolhion N, Sokol H, Dorothée G, Lemere CA, Krantic S.

Mol Neurodegener. 2022 Mar 5;17(1):19. doi: 10.1186/s13024-022-00522-2.

Sixteen Weeks of Aerobic Exercise does not Alter Resting-state Connectivity of the Precuneus in Patients with Alzheimer's Disease

Musaeus CS, Johansen LB, Hasselbalch S, Beyer N, Høgh P, Siebner HR, Frederiksen KS.

Curr Alzheimer Res. 2022;19(2):171-177. doi: 10.2174/1567205019666220304091241.

Loneliness as Risk Factor for Alzheimer´s disease

Ávila-Villanueva M, Gómez-Ramírez J, Ávila J, Fernández-Blázquez MA.

Curr Aging Sci. 2022 Aug 4;15(3):293-296. doi: 10.2174/1874609815666220304195049.

A Systematic Review of Neuroimaging Studies Comparing Individuals with Subjective Cognitive Decline to Healthy Controls

Parker AF, Ohlhauser L, Scarapicchia V, Smart CM, Szoeke C, Gawryluk JR.

J Alzheimers Dis. 2022;86(4):1545-1567. doi: 10.3233/JAD-215249.

The Role of Immunity in Alzheimer's Disease

McManus RM.

Adv Biol (Weinh). 2022 May;6(5):e2101166. doi: 10.1002/adbi.202101166. Epub 2022 Mar 7.

Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device

Epelbaum S, Burgos N, Canney M, Matthews D, Houot M, Santin MD, Desseaux C, Bouchoux G, Stroer S, Martin C, Habert MO, Levy M, Bah A, Martin K, Delatour B, Riche M, Dubois B, Belin L, Carpentier A.

Alzheimers Res Ther. 2022 Mar 8;14(1):40. doi: 10.1186/s13195-022-00981-1.

Effect of light therapy on delirium in older patients with Alzheimer's disease-related dementia

Zou C, Mei X, Li X, Hu J, Xu T, Zheng C.

J Psychiatr Res. 2022 May;149:124-127. doi: 10.1016/j.jpsychires.2022.03.003. Epub 2022 Mar 6.

Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis

Wang X, Li F, Gao Q, Jiang Z, Abudusaimaiti X, Yao J, Zhu H.

J Alzheimers Dis. 2022;87(1):285-304. doi: 10.3233/JAD-215394.

Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial

Krause-Sorio B, Siddarth P, Kilpatrick L, Milillo MM, Aguilar-Faustino Y, Ercoli L, Narr KL, Khalsa DS, Lavretsky H.

J Alzheimers Dis. 2022;87(2):569-581. doi: 10.3233/JAD-215563.

Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials

Lacorte E, Ancidoni A, Zaccaria V, Remoli G, Tariciotti L, Bellomo G, Sciancalepore F, Corbo M, Lombardo FL, Bacigalupo I, Canevelli M, Piscopo P, Vanacore N.

J Alzheimers Dis. 2022;87(1):101-129. doi: 10.3233/JAD-220046.

Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study

Morton H, Basu T, Bose C, Reddy PH.

J Alzheimers Dis. 2022;87(1):33-49. doi: 10.3233/JAD-220084.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias